STOCKHOLDERS' DEFICIENCY: Board of Directors fees (Details) - USD ($) |
9 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2020 |
Sep. 30, 2019 |
Dec. 31, 2019 |
Dec. 31, 2018 |
|
| Directors' fees | $ 1,272,866 | $ 222,614 | $ 232,614 | $ 424,065 |
| Transaction 2 | ||||
| Sale of Stock, Transaction Date | Sep. 28, 2018 | |||
| Sale of Stock, Description of Transaction | the board of directors granted to each of its directors warrants to purchase 500,000 shares of common stock | |||
| Sale of Stock, Price Per Share | $ 0.14 | |||
| Transaction 3 | ||||
| Sale of Stock, Transaction Date | Sep. 26, 2019 | |||
| Sale of Stock, Description of Transaction | the board of directors granted to each of its directors warrants to purchase 500,000 shares of common stock | |||
| Sale of Stock, Price Per Share | $ 0.08 | |||
| X | ||||||||||
- Definition Represents the monetary amount of Directors' fees, during the indicated time period. No definition available.
|
| X | ||||||||||
- Definition Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
| X | ||||||||||
- Definition Date the subsidiary or equity investee issued or sold stock, in CCYY-MM-DD format. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|